Emergent BioSolutions, Inc. (EBS)
10.93
-0.06
(-0.55%)
USD |
NYSE |
Feb 20, 16:00
10.94
+0.01
(+0.09%)
After-Hours: 20:00
Emergent BioSolutions Market Cap : 574.04M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 110.60B |
| Eli Lilly & Co. | 952.34B |
| Penumbra, Inc. | 13.31B |
| Disc Medicine, Inc. | 2.316B |
| MetaVia, Inc. | 39.37M |
Market Cap Related Metrics
| PE Ratio | 8.447 |
| PS Ratio | 0.7696 |
| Price to Book Value | 0.9855 |
| Price to Free Cash Flow | 433.69 |
| Price | 10.93 |
| Earnings Yield | 11.84% |
| Operating PE Ratio | 5.234 |
| Normalized PE Ratio | 8.657 |